SIMCERE PHARMA (02096) announced that on January 12, 2026, the company repurchased 3.672 million of its own shares at a total cost of HK$41.9453 million. The repurchase price per share ranged from HK$11.1975 to HK$11.6.
SIMCERE PHARMA (02096) announced that on January 12, 2026, the company repurchased 3.672 million of its own shares at a total cost of HK$41.9453 million. The repurchase price per share ranged from HK$11.1975 to HK$11.6.
Comments